Dupont Capital Management Corp Neurocrine Biosciences Inc Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$106.72 - $127.06 $46,423 - $55,271	-435 Reduced 15.49%	2,374 $0
Q3 2022 Oct 31, 2022	SELL	$92.03 - $107.81 $94,146 - $110,289	-1,023 Reduced 26.7%	2,809 $298,000
Q2 2022 Jul 26, 2022	SELL	$75.79 - $100.07 $68,665 - $90,663	-906 Reduced 19.12%	3,832 $374,000
Q1 2022 Apr 27, 2022	BUY	$72.45 - $94.81 $117,369 - $153,592	1,620 Added 51.96%	4,738 $444,000
Q4 2021 Jan 31, 2022	SELL	$79.65 - $106.22 $255,835 - $341,178	-3,212 Reduced 50.74%	3,118 $266,000
Q3 2021 Nov 03, 2021	SELL	$86.18 - $99.03 $192,439 - $221,133	-2,233 Reduced 26.08%	6,330 $607,000
Q2 2021 Jul 30, 2021	BUY	$89.43 - $102.27 $448,491 - $512,884	5,015 Added 141.35%	8,563 $833,000
Q1 2021 Apr 29, 2021	BUY	$87.57 - $119.4 $210,080 - $286,440	2,399 Added 208.79%	3,548 $345,000
Q3 2020 Oct 29, 2020	SELL	$96.16 - $135.15 $166,549 - $234,079	-1,732 Reduced 60.12%	1,149 $110,000
Q2 2020 Jul 24, 2020	BUY	$85.09 - $130.36 $245,144 - $375,567	2,881 New	2,881 $351,000
Q4 2019 Jan 27, 2020	SELL	$86.8 - $118.57 $178,460 - $243,779	-2,056 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$83.82 - $101.5 $172,333 - $208,684	2,056 New	2,056 $185,000
Q1 2019 Apr 30, 2019	SELL	$69.31 - $91.53 $242,585 - $320,355	-3,500 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$68.32 - $124.36 $643,027 - $1.17 Million	-9,412 Reduced 72.89%	3,500 $250,000
Q3 2018 Nov 05, 2018	BUY	$98.88 - $125.85 $787,183 - $1 Million	7,961 Added 160.8%	12,912 $1.59 Million
Q2 2018 Jul 30, 2018	SELL	$75.3 - $105.99 $321,079 - $451,941	-4,264 Reduced 46.27%	4,951 $486,000
Q1 2018 May 02, 2018	SELL	$75.88 - $92.43 $6.58 Million - $8.02 Million	-86,748 Reduced 90.4%	9,215 $764,000
Q4 2017 Jan 31, 2018	BUY	$58.53 - $77.59 $1.37 Million - $1.82 Million	23,466 Added 32.37%	95,963 $7.45 Million
Q3 2017 Oct 31, 2017	BUY	$47.97 - $61.28 $3.48 Million - $4.44 Million	72,497	72,497 $4.44 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.96 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.38 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$710 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$355 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$257 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account